Identifying and addressing mild cognitive impairment (MCI) and other neurological conditions is difficult, subjective, and costly. In a partnership with […]Read more
In recent years, the fields of voice biomarkers and emotional analysis have garnered significant attention for their potential applications in […]Read more
One of the most robust voice biomarker studies ever conducted has been launched at Ulster University using Canary Speech’s patented […]Read more
Schedule a demo with us to learn how Canary's patented vocal biomarker platform works. Explore assessments and screening to see how Canary analyzes and tracks the presence and severity of targeted illnesses.